LTR Pharma Limited (AU:LTP) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LTR Pharma Limited has partnered with Men’s Health Downunder to provide its innovative erectile dysfunction treatment, SPONTAN®, through an established pharmacy network in Australia. This collaboration leverages Men’s Health Downunder’s extensive referral network and is a strategic step in commercializing SPONTAN®, aiming for broader market access by early 2025. The partnership underscores LTR Pharma’s commitment to enhancing men’s health through trusted healthcare providers.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.